162 results on '"Vitzthum, L."'
Search Results
2. Analysis of the Measured FDG Uptake from the First-in-Human Clinical Trial of Biology-Guided Radiotherapy
3. Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016
4. Workflow Considerations for Biology-Guided Radiotherapy (BgRT) Implementation
5. First-Year Experience of IMRT/SBRT Treatments Using a Novel Biology-Guided Radiation Therapy System
6. Patterns of Failure for Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer
7. Hyperfractionated Reirradiation for Locally Recurrent Thoracic Tumors
8. Mitigation of IMRT/SBRT Treatment Planning Errors on the First Biology-Guided Radiotherapy System Using FMEA within Six Sigma Framework
9. Comparison of Plan Quality Metrics after Left Anterior Descending Coronary Artery Sparing in VMAT Esophageal Radiotherapy
10. Predicting Local Control with Dosimetric Parameters in Patients Receiving Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
11. Imaging Performance of the PET Scan on a Novel Ring Gantry-Based PET/CT Linear Accelerator System in the First-in-Human Study of Biology-Guided Radiotherapy
12. A Technology-Informed Approach to Clinical Trial Equity
13. Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer Radiotherapy
14. Safety of Radiation Therapy for Treatment of Malignancy in Patients with Inflammatory Bowel Disease
15. MO-0876 BIOGUIDE-X: A First-in-Human Study of the Performance and Safety of Biology-Guided Radiotherapy
16. Mitigation of IMRT/SBRT treatment planning errors on the novel RefleXion X1 system using FMEA within Six Sigma framework
17. Investigating the Impact of Coronary Artery Dosimetry on Major Adverse Cardiac Events after Thoracic Radiation Therapy
18. Implementation and Case Study of a Clinical Research Data Warehouse in Radiation Oncology
19. Characterizing Metastatic Non-Small Cell Lung Cancer Presenting to an Academic Medical Center in an Era of Changing Treatment Paradigms
20. Outcomes and Imaging Analysis in Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy
21. IMRT and SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System
22. OA14.04 Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
23. Post-Treatment Evaluation of Swallowing Function Using Quantitative Videofluoroscopy in Head and Neck Patients Undergoing Immunoradiotherapy or Chemoradiotherapy
24. Lung Cancer Survival Trends in the Veterans Health Administration
25. Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images
26. Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
27. SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System
28. Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
29. The kVCT System Commissioning of a Novel Medical Linear Accelerator Designed for Biology-Guided Radiotherapy
30. Initial Evaluation of Biology-Guided Radiotherapy (BgRT) Plans Generated Using PET Acquired on the First Installation of New System
31. Rectosigmoid Cancer — Rectal Cancer or Sigmoid Cancer?
32. Analysis of Pathologic Complete Response Rates Between Different Neoadjuvant Radiation Treatment Regimens for Rectal Cancer
33. Comparison of a First-in-Class LINAC-Integrated PET System and a Diagnostic PET/CT Scanner
34. The Utility of Stereotactic Body Radiotherapy for Pelvic Recurrences After Prior Radiation Therapy
35. First Beam Commissioning Report of a Novel Medical Linear Accelerator Designed for Biologically Guided Radiotherapy
36. Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents
37. Rates of New Opioid Prescription during Curative Intent Cancer Treatment by Race and Socioeconomic Status
38. Competing Risk Analysis to Address Selection Bias in Comparative Effectiveness Research
39. Characterization and Prediction of Opioid Use in Head and Neck Cancer Patients Undergoing Local Therapy
40. Risk of Pelvic Fracture by Type of Radiation Therapy in Older Patients
41. Combined Androgen Blockade in Men with Intermediate and High Risk Localized Prostate Cancer Treated with Definitive Radiation Therapy
42. Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors
43. Racial Equity among African-American and Non-Hispanic White Men Diagnosed with Prostate Cancer in the Veterans Affairs Healthcare System
44. Association between Tobacco Smoking and Prostate Cancer-Specific Mortality in the Veterans Affairs Healthcare System
45. eHealth Survey of Spanish Speaking Patients and Caregivers
46. Assessment of Interrater Reliability for Comorbidity Indices in Determining Eligibility for Treatment Intensification in Head and Neck Cancer
47. Patterns of Care Among Elderly US Veterans Treated for Head and Neck Cancer with Radiation Therapy
48. Variation in Hematologic Toxicity in Patients Undergoing Radiation Therapy with Concurrent Weekly Cisplatin for Head and Neck Versus Cervical Cancer
49. Prognostic Role of p16 in Non-oropharyngeal Head and Neck Cancer
50. A Web-Based Tool to Compare Comorbidity Models and Geriatric Risk-Assessment in Head and Neck Cancer Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.